Light Therapy in the Treatment of Leg Pain

NCT ID: NCT00253981

Last Updated: 2016-06-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-11-30

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to apply Anodyne therapy to active duty soldiers, who have shin splints, to evaluate healing time and effectiveness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tibial stress reactions and fractures are often difficult to treat, and therefore, many soldiers proceed to a medical disability/discharge. It is felt that with the use of the MIRE technology, active duty soldiers with tibial stress reactions and fractures will heal more quickly and completely. All soldiers will have a documented bone scintigraph as evidence for tibial stress reaction or fracture prior to enrollment. In addition, pain-pressure goniometric measures and time to complete the Balke protocol will also be used to assess healing with the MIRE technology.

Comparison: Soldiers with Active MIRE technology, compared to soldiers with Placebo MIRE technology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tibial Fractures Leg Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infrared Light Therapy

Intervention: The use of infrared light therapy for the treatment of tibial fracture. The treatment was assigned three times a week for four weeks.

Group Type EXPERIMENTAL

Monochromatic Near-Infrared Light Energy (MIRE)

Intervention Type DEVICE

Subjects randomized to the intervention group (Monochromatic Near-Infrared Light Energy), received treatment three times a week for a total of four weeks.

Standard of Care

Standard of care was characterized by the use of standard medical treatment to include medication.

Group Type PLACEBO_COMPARATOR

Monochromatic Near-Infrared Light Energy (MIRE)

Intervention Type DEVICE

Subjects randomized to the intervention group (Monochromatic Near-Infrared Light Energy), received treatment three times a week for a total of four weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Monochromatic Near-Infrared Light Energy (MIRE)

Subjects randomized to the intervention group (Monochromatic Near-Infrared Light Energy), received treatment three times a week for a total of four weeks.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Active duty soldier
* Exertional leg pain of greater than 3 months duration
* Documented bone scintigraphic evidence for tibial stress reaction or fracture

Exclusion Criteria

* Known leg Pathology other than stress reaction or fracture
* Service members known to be leaving area within next 6 months
* Pregnant females
* High risk cardiopulmonary patients
* Patients with assisted walking devices
* Patients with two or more cardiac risk factors
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

William Beaumont Army Medical Center

FED

Sponsor Role collaborator

Samueli Institute for Information Biology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

LTC Richard P Petri, MD

Role: PRINCIPAL_INVESTIGATOR

Department of the Army

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

William Beaumont Army Medical Center

El Paso, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIRO #2005705

Identifier Type: OTHER

Identifier Source: secondary_id

NCT00253981

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

WBAMC #05/13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.